Laboratory Corp. Of America Holdings LH

NYS: LH | ISIN: US50540R4092   25/04/2024
198,35 USD (-4,61%)
(-4,61%)   25/04/2024

25 april 2024 · Labcorp Announces 2024 First Quarter Results · Persbericht

25 april 2024 · Labcorp Announces Winning Bid for Select Assets of Invitae · Persbericht

25 april 2024 · Invitae Enters into Agreement with Labcorp for Sale of Business · Persbericht

15 april 2024 · Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw · Persbericht

11 april 2024 · Labcorp Declares Quarterly Dividend · Persbericht

10 april 2024 · Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit · Persbericht

8 april 2024 · Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs · Persbericht

5 april 2024 · Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research · Persbericht

2 april 2024 · Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research · Persbericht

29 maart 2024 · The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab · Persbericht

28 maart 2024 · Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business · Persbericht

27 maart 2024 · Labcorp to Announce First Quarter Financial Results on April 25, 2024 · Persbericht

20 maart 2024 · Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials · Persbericht

16 maart 2024 · Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer · Persbericht

7 maart 2024 · Labcorp Launches Weight Loss Management Testing Solutions · Persbericht

15 februari 2024 · Labcorp Announces 2023 Fourth Quarter and Full Year Results · Persbericht

1 februari 2024 · Labcorp Named One of the World's Most Admired Companies™ by FORTUNE® Magazine · Persbericht

31 januari 2024 · Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women · Persbericht

16 januari 2024 · Labcorp to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 · Persbericht

12 januari 2024 · Labcorp Declares Quarterly Dividend · Persbericht

Mijn selecties